The effect of an antiviral peptide on the ribosomal reactions of the peptide elongation enzymes, EF-I and EF-II.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001665:Binding Sites; D002247:Carbon Isotopes; D005914:Globins / Q000096:biosynthesis; D006150:Guanine Nucleotides / Q000378:metabolism; D006868:Hydrolysis; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D010452:Peptide Biosynthesis; D010445:Peptide Elongation Factors; D010455:Peptides / Q000494:pharmacology*; D010649:Phenylalanine; D010759:Phosphorus Isotopes; D010944:Plants; D011072:Poly U / Q000096:biosynthesis; D011189:Potassium Chloride / Q000494:pharmacology; D011485:Protein Binding; D012343:RNA, Transfer / Q000378:metabolism; D011817:Rabbits; D012156:Reticulocytes / Q000166:cytology / Q000201:enzymology; D012270:Ribosomes / Q000201:enzymology*; D013997:Time Factors; D046249:Transfer RNA Aminoacylation; D014316:Tritium
D000998:Antiviral Agents; D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D010445:Peptide Elongation Factors; D010455:Peptides; D010759:Phosphorus Isotopes; D014316:Tritium; D011072:Poly U; D010649:Phenylalanine; D011189:Potassium Chloride; D005914:Globins; D012343:RNA, Transfer; D008274:Magnesium